Vaccination with dendritic cell–tumor fusion cells in multiple myeloma patients: a promising strategy?

By Garcia-Marquez Maria A   Shimabukuro-Vornhagen Alexander   Theurich Sebastian   von Bergwelt-Baildon Michael  

Immunotherapy, Vol. 5, Iss. 10, 2013-10 ,pp. : 1039-1042

Future Medicine

Access to resources Recommend Favorite

The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 94-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo homing and differentiation characteristics of mature (CD45 - ) and immature (CD45 + ) 5T multiple myeloma cells

By Asosingh K.   De Raeve H.   Croucher P.   Goes E.   Van Riet I.   Van Camp B.   Vanderkerken K.  

Experimental Hematology, Vol. 29, Iss. 1, 2001-01 ,pp. : 77-84

Elsevier

Access to resources Recommend Favorite

Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?

By Saatci Cetin   Caglayan A. Okay   Kocyigit Ismail   Akalin Hilal   Kaynar Leyla G.   Altuntas Fevzi   Eser Bulent   Demir Muzaffer   Cetin Mustafa   Ozkul Yusuf  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 39-42

Maney Publishing

Access to resources Recommend Favorite

Efficient presentation of tumor idiotype to autologous T cells by CD83 + dendritic cells derived from highly purified circulating CD14 + monocytes in multiple myeloma patients

By Ratta M.   Curti A.   Fogli M.   Pantucci M.   Viscomi G.   Tazzari P.   Fagnoni F.   Vescovini R.   Sansoni P.   Tura S.   Lemoli R.M.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 931-940

Elsevier

Access to resources Recommend Favorite